Open Access, High Ambitions
By Richard Gallagher
Fueled by scientists' resentment at perceived exploitation by established publishers, and driven by new opportunities in information technology, open access publishing burst onto the scene in biomedicine about five years ago. Most readers of The Scientist will be aware of the principal, two-part, argument in its favor, namely that:
- Maximum dissemination of properly peer-reviewed research is good for authors, good for funders, and, most importantly, good for progress of science, and
- Maximum dissemination is best ensured by immediate free access to published research papers.
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?